Episode 92: Doxorubicin: The Infamous Red Devil

ONS member Christine Rimkus, RN, MSN, AOCN®, clinical nurse specialist for the Siteman Cancer Center at Washington University in St. Louis, MO, and member of the St. Louis ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss doxorubicin—otherwise known as the red devil—chemotherapy administration, what nurses need to know about vesicants in practice, and how to support and advocate for patients receiving doxorubicin treatment. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons: By Attribution 3.0 Episode Notes Check out these resources from today’s episode: The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.  Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil The Case of the Vexing Vesicant Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice Understanding and Managing Oncologic Emergencies: A Resource for Nurses (Third Edition)